IMIDomics Collaborates with Gossamer Bio to Develop Therapies for Treating Immune-Mediated Inflammatory Diseases
Shots:
- The companies collaborates on multiple projects- being the first for inflammatory bowel disease(IBD) to develop and discover therapies for treating Immune-Mediated Inflammatory Diseases (IMIDs)
- The focus of the collaboration will allow Gossamer’s immunology research and development team to utilize IMIDomics’ unique clinical and molecular patient database for product discovery and development strategy
- IMIDomics’ platform has access to dynamic and high-quality IMID patient biobank- clinical data- proprietary multiomics molecular data and world-class clinical expertise
Click here to read full press release/ article | Ref: BioSpace | Image: Behance
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com